EMJ | Elevating the quality of healthcare globally

This site is intended for healthcare professionals

Continue

Latest News

All News
Clopidogrel Monotherapy After PCI Lowers Risk – EMJ
Cardiology
4 Sep 2026

Clopidogrel Monotherapy Lowers Ischaemic Risk After PCI

A nationwide study of more than 49,000 patients found clopidogrel monotherapy after PCI reduced ischaemic events and myocardial infarction risk.
Dermatology
4 Sep 2026

Pleomorphic Dermal Sarcoma Shows Genetic Similarity to CSCC

A cohort study found pleomorphic dermal sarcoma shared key genetic features with metastatic cutaneous squamous cell carcinoma but differed from soft-tissue sarcoma.
Neurology
4 Sep 2026

Vitamin B12 Deficiency Identified in Idiopathic Myelopathy Cases

A study of 148 patients has found anti-CD320 antibodies and CNS vitamin B12 deficiency in a subset of patients with idiopathic myelopathy.
Time-Restricted Eating May Improve MASLD Outcomes
Hepatology
4 Sep 2026

Time-Restricted Eating Linked to Improved Liver Health

Time-restricted eating was linked to sustained improvements in liver fat and fibrosis-related measures in MASLD.
AI Speeds Chest X-Ray Reading but Not Accuracy - EMJ
Radiology
4 Sep 2026

AI Speeds Chest X-Ray Reading Without Improving Accuracy

AI made chest X-ray interpretation faster and boosted confidence, but failed to improve diagnostic accuracy.
Diabetes
3 Sep 2026

Ketogenic Diet Shows Added Metabolic Benefits Beyond Weight Loss

A ketogenic diet reduced liver fat and improved glucose control in adults with obesity, prediabetes, and fatty liver disease.
Doctor in white coat holding urine test
General Healthcare
3 Sep 2026

At-Home Urine Test Could Diagnose Majority of Bladder Cancer Cases

A new urine test detected 92% of bladder cancers in an NHS study and could help reduce the number of patients requiring urgent cystoscopies.
Urology
3 Sep 2026

Specialist Referral Improves Cardiovascular Risk in Prostate Cancer

A randomised trial found that specialist referral improved cardiovascular risk-factor control in patients with prostate cancer, particularly cholesterol, but did not reduce major cardiovascular events.
Innovations
3 Sep 2026

AI Lymphocyte Scoring Refines Breast Cancer Prognosis

AI-based lymphocyte scoring provided prognostic information in HER2-positive breast cancer, spatial measures added data beyond immune cell density. 

Latest Articles

Interactive Content

Allergy & Immunology
4 Sep 2026

Navigating the Diagnosis of Refractory Chronic Cough

A 60-year-old White female has been referred by her PCP to the pulmonologist for “investigation and treatment of worsening…
Respiratory
28 Aug 2026

Chronic Cough Mechanism and Treatment​

Chronic cough, defined as a cough that lasts ≥8 weeks, is highly prevalent in patients with IPF. It is reported in approximately 85% of…
Respiratory
17 Jul 2026

Extracorporeal CO₂ Removal in Clinical Practice

This interactive case study allows clinicians to examine a patient with COPD presenting with an acute exacerbation…
General Healthcare
10 Jul 2026

The European Clinician's Guide to AI Tools

Explore approved AI tools for EU and UK clinicians in 2026, with evidence, CE/MHRA status, and practical guidance across specialties.
All Interactive Content

Latest Infographics

All Infographics
Respiratory
28 Aug 2026

Chronic Cough Mechanism and Treatment​

Chronic cough, defined as a cough that lasts ≥8 weeks, is highly prevalent in patients with IPF. It is reported in approximately 85% of…
Flagship Journal
11 Aug 2026

When Inflammation Becomes Visible: Understanding its Burden

AD is a common, chronic, immune-mediated, inflammatory skin disease. Hand involvement is present in up to 56% of patients with moderate…
Microbiology & Infectious Diseases
29 Jul 2026

Balancing speed and stewardship in AMR

In the UK, Fetcroja® (Cefiderocol) is indicated for the treatment of infections due to aerobic Gram-negative organisms in adults with…
Microbiology & Infectious Diseases
28 Jul 2026

Overcoming Cefiderocol AST Challenges in MDR-GN Infections: A Stepwise Approach

Inappropriate and delayed appropriate antibiotic therapy has a major impact on survival.1,2Antimicrobial susceptibility results obtained as…

Latest Podcasts

All Podcasts
Bjørn Henning Grønberg
Oncology
1 Sep 2026

Onc Now: Small-Cell Lung Cancer and Beyond

In this episode, Bjørn Henning Grønberg explores the evolving landscape of lung cancer care, progress and remaining challenges…
Radiology
28 Aug 2026

Innovation, Research, and Inclusion in Interventional Radiology

In this series, host Saranya Ravindran speaks with Lakshmi Ratnam about the evolving landscape of interventional radiology and how…
Hematology
26 Aug 2026

Hema Now: What’s Next in Leukaemia Treatment?

Daniel DeAngelo, Chief of the Division of Leukemia, Dana-Farber Cancer Institute; and Professor of Medicine, Harvard Medical School…
General Healthcare
24 Aug 2026

Innovation, Research, and Inclusion in Healthcare Equity

In this series, host Catherine Glass speaks with Carl Streed Jr about advancing equity and inclusion for sexual…

Latest Videos & Webinars

All Videos & Webinars
Gastroenterology
27 Aug 2026

Rome V and Functional Dyspepsia

Watch expert-led discussions on the latest Rome V guidance for functional dyspepsia, from diagnosis and biology to evidence-based…
Reproductive Health
24 Aug 2026

Our Latest Reproductive Health Journal

EMJ’s latest Reproductive Health journal is now live! Inside, explore highlights and insights from ESHRE 2026. Discover insights from…
Hematology
21 Aug 2026

EHA 2026: Claire Harrison on MPNs, Myelofibrosis, and JAK Inhibitors

EMJ spoke with Claire Harrison about receiving the EHA 2026 Lifetime Achievement Award, her pioneering work in MPNs.
We’ve noticed you’re accessing
from North/South America.